initi
recogn
physiolog
regul
blood
pressur
bodi
fluid
homeostasi
angiotensin
ang
discov
actual
pressor
substanc
anim
model
renal
hypertens
consid
primari
effector
molecul
ra
regul
blood
pressur
vasoconstrict
fluid
homeostasi
braunmenendez
et
al
page
helmer
gener
ang
ii
occur
two
enzymat
step
aspartyl
proteas
renin
produc
special
juxtaglomerular
smooth
muscl
cell
kidney
respons
reduc
renal
perfus
pressur
salt
deplet
catalyz
first
ratelimit
reaction
split
leuval
peptid
bond
human
leuleu
bond
speci
releas
final
ten
ntermin
amino
acid
known
substrat
angiotensinogen
agt
agt
liverderiv
globulin
belong
famili
serineproteas
inhibitor
serpin
concentr
major
determin
system
renin
activ
peptid
fragment
result
cleavag
agt
ang
inact
precursor
ang
ii
ang
ii
gener
cleavag
two
ctermin
amino
acid
hisleu
ang
dipeptidyl
carboxypeptidas
angiotensinconvert
enzym
ace
anchor
lumin
surfac
endothelium
transmembran
ectoenzym
particularli
abund
pulmonari
vasculatur
caldwel
et
al
recent
advanc
metabol
angiotensin
peptid
reveal
novel
function
peptid
challeng
view
ang
ii
primari
effector
ra
figur
aminopeptidas
split
asp
ang
ii
yield
less
potent
vasoconstrictor
ang
iii
ang
transform
ang
iv
ang
aminopeptidas
n
anoth
angiotensin
peptid
ang
deriv
either
directli
ang
tissueendopeptidas
ang
ii
act
vasodil
ferrario
iyer
ace
homologu
act
carboxypeptidas
select
remov
ctermin
phe
ang
ii
contribut
ang
ii
degrad
well
ang
gener
receiv
much
attent
oppos
factor
ang
ii
action
highlight
heterogen
function
variou
ra
compon
also
recogn
function
receptor
sar
coronaviru
mediat
cell
intrus
kuhn
et
al
vascular
wall
possess
abil
independ
gener
ang
ii
suggest
local
paracrineautocrin
function
ang
ii
except
renin
compon
ra
found
vascular
wall
ratelimit
step
local
ang
ii
gener
convers
ang
ang
ii
catalyz
number
enzym
addit
ace
name
chymas
cathepsin
g
chymostatinsensit
ang
iigener
enzym
cage
sever
reninlik
enzym
releas
ang
agt
cathepsin
tonin
tissu
plasminogen
activ
aspartyl
proteas
propos
mean
mediat
local
ra
independ
kidneyderiv
renin
convinc
evid
local
synthesi
renin
hilger
et
al
tissu
level
renin
becom
undetect
within
hour
bilater
nephrectomi
thurston
et
al
suggest
accumul
renin
tissu
renin
uptak
cardiovascular
tissu
report
result
sustain
ang
ii
effect
local
vascular
bed
et
al
furthermor
function
renin
receptor
recent
found
mesangi
cell
enhanc
catalyt
activ
renin
upon
bind
nguyen
et
al
receptor
specif
bind
renin
precursor
prorenin
may
explain
local
concentr
renin
eg
interstiti
fluid
oftentim
higher
predict
simpl
diffus
plasma
danser
et
al
cellular
effect
ang
ii
mediat
distinct
highaffin
cell
surfac
receptor
two
subtyp
discrimin
specif
nonpeptid
antagonist
addit
exposur
sulfhydrylreduc
dithiothreitol
dtt
inactiv
ang
ii
type
receptor
rs
wherea
ang
ii
type
receptor
rs
remain
intact
chiu
et
al
r
initi
clone
rat
aortic
smooth
muscl
bovin
adren
cell
murphi
et
al
sasaki
et
al
r
clone
rat
pheochromocytoma
cell
line
fetal
rat
tissu
kambayashi
et
al
mukoyama
et
al
addit
receptor
subtyp
eg
r
r
describ
pharmacolog
base
bind
studi
brain
r
origin
defin
bind
site
hexapeptid
ang
iv
later
r
found
ident
insulinregul
aminopeptidas
irap
protein
first
identifi
membranebound
metalloproteas
insulinsensit
vesicl
fat
muscl
cell
keller
et
al
ang
iv
bind
inhibit
irap
enhanc
cognit
function
experiment
anim
chai
et
al
human
r
r
singlecopi
gene
rodent
two
r
gene
loci
chromosom
chromosom
accordingli
express
two
r
isoform
r
r
differ
amino
acid
mainli
carboxytermin
region
overal
homolog
pharmacolog
indistinguish
iwai
inagami
rs
express
predominantli
vascular
smooth
muscl
endotheli
cell
liver
lung
kidney
brain
ovari
testi
wherea
rs
occur
mainli
adren
anterior
pituitari
gland
burson
et
al
human
r
homolog
rodent
isoform
curnow
et
al
vascular
ang
ii
effect
known
date
mediat
rs
bestcharacter
ang
ii
receptor
far
r
block
biphenylimidazol
includ
losartan
dup
valsartan
candesartan
mainli
express
vascular
smooth
muscl
cell
vsmc
also
heart
lung
liver
adren
cortex
kidney
brain
sever
report
show
ang
ii
effect
endotheli
cell
alway
seem
mediat
known
ang
ii
receptor
vaughan
et
al
asid
rodent
endotheli
cell
clearli
express
rs
rs
also
found
bovin
porcin
endotheli
cell
primari
cultur
human
arteri
umbil
endotheli
cell
rs
detect
bind
studi
howev
receptor
rapidli
disappear
vitro
interestingli
lowaffin
bind
site
persist
even
later
cell
passag
inhibit
specif
receptor
blocker
ko
et
al
hand
rs
found
human
endotheli
cell
use
immunohistochemistri
allen
et
al
r
seventransmembranedomain
rhodopsinlik
peptiderg
gproteincoupl
receptor
gpcr
upon
ligand
bind
activ
heterotrimer
gprotein
direct
subsequ
signal
event
r
amino
acid
mw
kda
structur
consist
four
extracellular
nterminu
three
connect
loop
four
intracellular
three
connect
loop
cterminu
seven
transmembran
domain
extracellular
glycosyl
site
nterminu
asn
second
extracellular
loop
asp
asn
desarnaud
et
al
two
disulfid
bond
extracellular
loop
one
two
extracellular
loop
three
nterminu
stabil
tertiari
structur
receptor
nterminu
well
first
third
extracellular
loop
contain
epitop
peptid
bind
bind
nonpeptid
antagonist
independ
epitop
suggest
distinct
mode
interact
peptid
nonpeptid
ligand
hjorth
et
al
sever
conserv
residu
asp
tyr
tyr
import
gprotein
bind
activ
mari
et
al
cytoplasm
tail
phosphoryl
basal
ang
iistimul
state
numer
ser
thr
residu
also
tyr
residu
posit
kai
et
al
among
aspproleuphetyr
nplfi
sequenc
variant
highli
conserv
tyrosinecontain
npxi
motif
found
cytoplasm
tail
mani
receptor
tyrosin
kinas
rtk
link
coat
pitmedi
receptor
intern
howev
r
nplfi
motif
link
receptor
intern
instead
extra
phe
seem
import
agonist
bind
hunyadi
et
al
tyr
also
part
function
import
motif
yipp
sequenc
similar
motif
plateletderiv
growth
factor
receptor
pdgfr
epiderm
growth
factor
receptor
egfr
phosphoryl
import
coupl
receptor
r
tyr
mediat
interact
ali
et
al
member
janu
famili
kinas
jak
also
import
egfr
transactiv
human
locat
chromosom
span
kb
includ
five
exon
four
intron
exon
size
rang
bp
exon
largest
code
exon
first
four
exon
encod
untransl
region
utr
guo
et
al
sever
splice
variant
differ
exon
composit
describ
open
read
frame
span
bp
polymorph
describ
potenti
link
vascular
morbid
singl
nucleotid
polymorph
snp
utr
common
hypertens
patient
normotens
control
bonnardeaux
et
al
addit
patient
coronari
arteri
diseas
cad
homozyg
mutat
allel
cc
genotyp
increas
r
sensit
van
geel
et
al
snp
implic
genet
hypertens
much
work
need
done
evalu
associ
snp
cardiovascular
diseas
densiti
ang
ii
receptor
vsmc
central
determin
cellular
sensit
ang
ii
thu
factor
regul
express
mark
effect
cardiovascular
function
among
cytokin
hormon
growth
factor
vasoact
agent
tabl
vascular
tissu
chronic
ang
ii
exposur
induc
downregul
r
neg
feedback
fashion
nickenig
et
al
mrna
protein
significantli
downregul
hour
ang
ii
exposur
vitro
lassegu
et
al
vivo
gunther
et
al
variou
pathophysiolog
condit
affect
r
regul
exampl
hypercholesterolemia
lead
r
overexpress
may
explain
hyperlipidemia
frequent
associ
hypertens
intriguingli
oxid
lowdens
lipoprotein
oxldl
link
earli
atherosclerot
event
increas
r
express
endotheli
cell
li
et
al
contrast
unmodifi
ldl
affect
r
express
vsmc
nickenig
et
al
coenzym
hmgcoa
reductas
inhibitor
statin
potent
cholesterollow
drug
shown
reduc
r
express
reduc
halflif
r
mrna
mechan
depend
inhibitori
effect
geranylgeranyl
may
therefor
explain
lipidlow
independ
pleiotrop
effect
statin
vasculatur
wassmann
et
al
proinflammatori
cytokin
increas
r
express
vascular
tissu
sasamura
et
al
wherea
nitric
oxid
downregul
transcript
ichiki
et
al
stabil
r
mrna
depend
specif
bind
motif
polysom
protein
utr
immedi
upstream
polyadenyl
tract
nickenig
et
al
two
put
polyadenyl
site
utr
well
six
auuua
motif
furuta
et
al
mutat
aurich
element
utr
decreas
r
mrna
decay
aurepeat
mrnabind
protein
promot
r
mrna
destabil
addit
primari
base
composit
secondari
structur
mrna
display
stemloop
sequenc
seem
necessari
interact
degrad
mrnabind
protein
berger
et
al
moreov
utr
sequenc
found
involv
posttranscript
regul
although
known
splice
variant
open
read
frame
affect
variant
leader
sequenc
contribut
tissuespecif
chang
express
least
part
alter
rate
mrna
translat
elton
martin
zhang
et
al
initi
mrna
synthesi
anoth
control
point
express
asid
bind
site
activ
protein
cyclic
amp
regulatori
element
cre
bind
site
eukaryot
transcript
factor
promot
includ
gcboxrel
sequenc
within
region
takeuchi
et
al
direct
bind
activ
peroxisom
proliferatoractiv
receptor
ppar
caus
inhibit
transcript
sugawara
et
al
anoth
gcboxrel
sequenc
locat
promot
rat
human
zhao
et
al
bind
site
addit
involv
drive
basal
express
kamb
et
al
also
suggest
increas
level
protein
hypothalamu
contribut
hypertens
phenotyp
spontan
hypertens
rat
shr
via
increas
r
express
kubo
et
al
proxim
tubular
cell
cisact
gagabox
also
identifi
import
regul
basal
growth
factorinduc
transcript
suggest
may
possess
altern
initi
site
wyse
et
al
although
singl
r
fulli
function
emerg
data
show
rs
capabl
form
homoand
heterom
gpcr
homodimer
r
monocyt
correl
enhanc
ang
ii
signal
monocyt
adhes
endothelium
coexpress
nonfunct
r
mutant
abrog
coupl
gprotein
wherea
recruit
subsequ
stimul
mitogenactiv
protein
kinas
mapk
pathway
remain
intact
suggest
oligomer
intact
rs
particularli
pertin
gprotein
signal
hansen
et
al
receptor
dimer
r
includ
bradykinin
b
receptor
adrenerg
receptor
dopamin
receptor
r
abdalla
et
al
abdalla
et
al
barkiharrington
et
al
zeng
et
al
rb
heterodim
confer
increas
ang
ii
sensit
increas
number
heterodim
clinic
correl
preeclampsia
quitter
et
al
conclus
determin
oligomer
affect
ligand
bind
sinc
data
suggest
may
occur
even
surfac
express
hansen
et
al
oligomer
may
differenti
coupl
r
specif
downstream
signal
protein
chang
receptor
ligand
bind
characterist
receptor
traffick
pattern
may
integr
inform
multipl
receptor
modul
ang
ii
sensit
cell
characterist
consequ
r
activ
cellular
desensit
ang
ii
within
minut
receptor
intern
via
clathrinco
pit
endosom
intracellular
ang
iiat
r
complex
continu
signal
inactiv
occur
either
degrad
fusion
lysosom
dephosphoryl
subsequ
recycl
cell
surfac
membran
hunyadi
et
al
approxim
intern
receptor
recycl
back
cell
membran
intern
cellular
process
ang
iiat
r
complex
may
specif
role
signal
transduct
engag
complex
second
messeng
system
cell
membran
princip
mechan
depend
serand
thrphosphoryl
activ
r
cterminu
mediat
gproteinrel
kinas
grk
phosphoryl
region
thr
ser
facilit
interact
qian
et
al
impair
gprotein
activ
subsequ
promot
receptor
endocytosi
kule
et
al
recruit
nonreceptor
tyrosin
kinas
nrtk
like
csrc
adapt
protein
cell
membran
form
complex
orchestr
intern
process
fessart
et
al
receptor
phosphoryl
grk
direct
signal
event
toward
mapk
pathway
independ
gprotein
kim
et
al
instanc
mutant
rs
incap
gprotein
coupl
found
activ
erk
via
wei
et
al
interest
hypertens
per
se
upregul
vsmc
vivo
suggest
modul
level
may
adapt
cellular
mean
autoregul
ang
ii
sensit
ishizaka
et
al
endocytosi
r
remain
tightli
bound
travel
earli
sort
endosom
complex
fuse
either
lysosom
perinuclear
recycl
endosom
sort
receptorligand
complex
intracellular
membran
organel
import
traffick
mechan
shown
rs
preferenti
traffic
endosom
seachrist
et
al
rab
gtpase
regul
intracellular
vesicl
transport
fusion
furthermor
bind
r
cterminu
appear
mediat
retent
complex
earli
endosom
therebi
prevent
recycl
degrad
dale
et
al
could
repres
mechan
prolong
ang
ii
effect
intracellularli
nuclear
accumul
r
also
describ
effect
cellular
prolifer
specul
r
directli
particip
transcript
regul
cook
et
al
interestingli
direct
microinject
ang
ii
vsmc
concomit
extracellular
r
blockad
demonstr
gener
intracellular
calcium
increas
howev
concomit
microinject
r
blocker
abolish
ang
ii
effect
haller
luft
confirm
function
coupl
ang
ii
r
intracellularli
seen
intern
process
describ
direct
action
free
intracellular
ang
ii
either
escap
intern
rang
iiligand
complex
synthes
de
novo
also
hypothes
function
relev
mechan
vivo
remain
determin
becom
appar
lipid
bilay
cell
membran
distinct
region
characterist
differ
function
particularli
relat
cell
signal
region
predominantli
compos
sphingolipid
cholesterol
outer
lipid
layer
call
lipid
raft
region
concentr
signal
protein
gprotein
suggest
lipid
composit
surround
gpcr
may
influenc
receptor
function
caveola
special
invagin
lipid
raft
character
presenc
caveolin
cav
particular
import
ang
ii
signal
upon
stimul
ang
ii
r
rapidli
min
transloc
later
cavenrich
membran
fraction
directli
interact
promot
assembl
cav
scaffold
domain
ishizaka
et
al
process
requir
function
cytoskeleton
cabl
actinbind
nrtk
direct
proper
transloc
r
lipid
raft
subsequ
nadph
oxidas
activ
eventu
mediat
vsmc
hypertrophi
zuo
et
al
possibl
r
complex
also
intern
noncoat
caveola
r
amino
acid
mw
kda
homolog
r
sequenc
locat
x
chromosom
mainli
express
uterin
smooth
muscl
brain
ovari
adren
medulla
heart
fetal
mesenchym
specif
antagon
tetrahydroimidazopyridin
like
wharton
et
al
wide
express
fetal
tissu
support
concept
modulatori
function
embryon
develop
howev
r
surfac
express
increas
certain
patholog
condit
instanc
heart
failur
patient
ratio
r
r
heart
increas
tsutsumi
et
al
addit
report
r
reexpress
vascular
inflamm
injuri
akishita
et
al
interestingli
gene
target
r
block
cardiac
hypertrophi
fibrosi
mice
ang
iiinduc
hypertens
ichihara
et
al
r
also
present
bovin
pulmonari
endotheli
cell
increas
endotheli
product
counterbal
rmediat
vasoconstrict
set
hypoxia
olson
et
al
contrast
r
r
undergo
receptor
intern
third
intracellular
loop
seem
carri
uniqu
featur
r
regard
gprotein
interact
lehtonen
et
al
express
also
regul
multipl
extracellular
factor
interestingli
ang
ii
infus
upregul
vascular
r
express
mesenter
arteri
rat
bonnet
et
al
ang
ii
activ
complex
seri
signal
event
tempor
spatial
tightli
control
second
messeng
system
activ
within
second
other
delay
persist
hour
griendl
et
al
upon
ang
ii
bind
vsmc
r
activ
gprotein
pertussi
toxininsensit
subfamili
q
within
sec
ang
ii
stimul
rapid
transient
activ
phosphatidylinositolspecif
membranebound
phospholipas
c
plc
lead
product
inositol
ip
diacylglycerol
dag
protein
well
respect
subunit
coupl
r
figur
subsequ
sec
activ
account
major
ip
product
activ
tyrosin
kinasedepend
manner
return
baselin
activ
min
ushiofukai
et
al
evid
exist
suggest
nrtk
src
respons
tyrosin
kinas
step
haendel
et
al
ip
rapidli
diffus
endoplasm
reticulum
er
bind
ip
receptor
releas
calcium
ca
cytosol
addit
ip
trigger
releas
ca
intracellular
ca
store
sustain
ang
iiinduc
vasoconstrict
depend
transmembran
ca
influx
ruan
arendshorst
product
membranebound
dag
ang
ii
biphas
initi
peak
sec
result
hydrolysi
phosphoinositid
plc
wherea
second
phase
maximum
min
result
phospholipas
pld
activ
activ
pld
csrc
rhoadepend
mechan
pld
remain
activ
least
hour
split
phosphatidylcholin
cholin
phosphatid
acid
pa
ushiofukai
et
al
subsequ
convert
dag
prolong
phase
dag
product
intern
ligandbound
r
complex
requir
impli
pld
activ
occur
spatial
separ
plasma
membran
dag
conjunct
phosphatidylserin
ca
subsequ
activ
protein
kinas
c
pkc
earli
increas
intracellular
ca
stimul
ca
calmodulindepend
myosin
light
chain
kinas
phosphoryl
ser
myosin
regulatori
light
chain
mlc
subsequ
vsmc
contract
mlc
interact
actin
process
importantli
modul
ca
sensit
myofila
larg
determin
rhoassoci
kinas
rock
mediat
inhibit
mlc
phosphatas
uehata
et
al
addit
ang
ii
rapidli
phosphoryl
activ
pla
produc
arachidon
acid
rao
et
al
cytochrom
metabolit
arachidon
acid
acid
implic
vasoconstrict
variou
vascular
bed
roman
control
relax
follow
contract
vital
dynam
regul
blood
vessel
diamet
henc
flow
termin
ang
ii
signal
achiev
regul
gprotein
ang
ii
upregul
mrna
pkcdepend
manner
therebi
provid
function
neg
feedback
grant
et
al
mice
dramat
increas
blood
pressur
due
prolong
respons
ang
ii
resist
vessel
evidenc
fact
hypertens
rapidli
revers
ang
ii
blockad
hexim
et
al
tissu
growth
character
cellular
hypertrophi
increas
protein
translat
cellular
hyperplasia
prolifer
increas
dna
synthesi
cell
cycl
progress
presum
inhibit
cell
death
pathway
latter
respons
eventu
depend
regul
gene
express
transcript
factor
although
extracellular
signal
regul
cell
growth
classic
q
fig
angiotensin
ii
stimul
vascular
smooth
muscl
cell
growthgrowthpromot
effect
ang
ii
larg
mediat
egfr
transactiv
stimul
tyrosin
kinas
signal
cascad
see
text
detail
adam
disintegrin
metalloproteinas
r
angiotensin
ii
type
receptor
egfr
epiderm
growth
factor
receptor
hbegf
heparinbind
epiderm
growth
factor
hsp
heat
shock
protein
jak
janu
kinas
jnk
cjun
nh
termin
kinas
pkc
protein
kinas
c
phosphatidylinositol
ro
reactiv
oxygen
speci
consid
mediat
growth
factor
cytokin
activ
rtk
nrtk
ang
ii
found
potent
growth
stimulu
vsmc
figur
reflect
increas
cell
volum
protein
content
geisterf
et
al
wherea
prolif
effect
ang
ii
found
depend
cellular
milieu
eg
autocrin
product
transform
growth
suppress
hyperplast
respons
gibbon
et
al
within
min
ang
ii
exposur
numer
cytosol
protein
found
tyrosin
phosphoryl
molloy
et
al
furthermor
growthpromot
effect
ang
ii
found
abrog
tyrosin
kinas
inhibitor
well
accept
ang
ii
rapidli
activ
mapk
famili
includ
cjun
nh
termin
kinas
jnk
also
term
stressactiv
protein
kinas
extracellular
signalregul
kinas
erk
mapk
mapk
consid
upstream
mediat
transcript
factor
involv
vsmc
growth
activ
ang
ii
block
plc
inhibit
intracellular
ca
chelat
tyrosin
kinas
inhibit
eventu
proce
rasdepend
pathway
eguchi
et
al
one
intermedi
tyrosin
kinas
r
ra
src
schieffer
et
al
growth
factor
receptor
typic
rtk
egfr
characterist
propag
signal
small
gtpase
ra
via
gtpexchang
factor
son
sevenless
so
form
multimer
signal
complex
receptor
adapt
protein
shc
importantli
demonstr
atyp
mediat
ang
ii
activ
ra
seem
uniqu
aspect
ang
iiinduc
respons
compar
growth
factor
liao
et
al
ang
ii
induc
egfr
activ
intracellular
ca
reactiv
oxygen
speci
ro
depend
mechan
term
egfr
transactiv
eguchi
et
al
ushiofukai
et
al
egfr
act
scaffold
mediat
number
downstream
signal
molecul
includ
phosphatidylinositol
akt
src
recruit
anoth
nrtk
focal
adhes
kinas
fak
famili
call
prolinerich
tyrosin
kinas
pyk
assembl
signal
complex
activ
subtyp
disintegrin
metalloproteas
adam
famili
releas
cell
surfacebound
egf
subsequ
activ
receptor
eguchi
et
al
ohtsu
et
al
prenzel
et
al
ra
import
consequ
ang
iiinduc
activ
conjunct
activ
increas
protein
translat
initi
interestingli
egfr
transactiv
requir
mapk
activ
jnk
activ
eguchi
et
al
parallel
independ
mechan
activ
ang
ii
occur
via
mention
wei
et
al
apoptosi
signalingrel
kinas
ask
requir
jnk
mapk
activ
tobium
et
al
jnk
activ
also
depend
rhorock
activ
subsequ
rac
stimul
ohtsu
et
al
activ
mapk
ang
ii
lead
stimul
heat
shock
akt
taniyama
et
al
latter
crucial
vsmc
hypertrophi
jak
classic
activ
cytokin
receptor
upstream
control
transcript
factor
signal
transduc
activ
transcript
stat
turn
regul
transcript
earli
growth
respons
gene
cfo
cmyc
cjun
horvath
darnel
bind
tyr
r
facilit
domaincontain
tyrosin
phosphatas
shp
marrero
et
al
sever
aspect
growthpromot
pathway
special
characterist
rosdepend
mean
enzym
activ
suscept
oxid
fact
mani
signal
protein
transcript
factor
protein
tyrosin
phosphatas
ptp
reli
reduc
cy
residu
activ
ang
ii
via
r
gener
ro
via
membranebound
multisubunit
protein
complex
call
nadph
oxidas
nox
arachidon
acid
metabolit
play
import
role
nox
activ
zafari
et
al
ro
turn
modifi
critic
signal
cascad
mapk
ushiofukai
et
al
sever
differ
isoform
nox
identifi
differ
subunit
composit
subcellular
local
probabl
type
ro
produc
bedard
kraus
hilenski
et
al
differ
ro
may
distinct
vascular
effect
instanc
vascular
hypertrophi
ang
iimedi
hypertens
mediat
vsmcderiv
h
main
effect
superoxid
inactiv
antiatherogen
rajagopalan
et
al
zhang
et
al
tissu
growth
also
occur
expans
noncellular
compon
chronic
ang
ii
stimul
collagen
product
kato
et
al
observ
frequent
refer
transform
vsmc
synthet
phenotyp
produc
proteoglycan
glycosaminoglycan
collagen
type
fibronectin
constitu
extracellular
matrix
synthet
phenotyp
vsmc
predomin
hypertens
anim
wherea
normotens
litterm
contain
vsmc
contractil
phenotyp
fukuda
et
al
time
vsmc
modul
extracellular
matrix
degrad
activ
matrix
metalloproteinas
mmp
extracellular
matrix
degrad
prerequisit
cell
migrat
one
hand
implic
plaqu
instabl
ang
iiinduc
vsmc
migrat
strongli
implic
atherosclerosi
restenosi
vascular
injuri
abnorm
accumul
vsmc
vessel
intima
entail
movement
media
prescott
et
al
suggest
vsmc
migrat
media
intima
result
pdgf
gradient
okuda
et
al
vitro
studi
confirm
ang
ii
also
capabl
stimul
vsmc
migrat
although
less
potent
pdgf
bell
madri
antagon
effect
dubey
et
al
role
ang
ii
neointima
format
restenosi
suggest
base
studi
show
tissu
ace
activ
elev
vessel
injuri
ace
inhibit
prevent
restenosi
rakugi
et
al
although
relev
observ
human
diseas
question
ang
ii
induc
vsmc
migrat
recruit
growth
pathway
egfrmapk
pathway
saito
et
al
xi
et
al
addit
cell
migrat
requir
dynam
reorgan
cytoskeleton
focal
adhes
complex
process
involv
src
activ
vsmc
ishida
et
al
ang
ii
stimul
phosphoryl
fak
paxillin
eguchi
et
al
leduc
meloch
okuda
et
al
regul
focal
adhes
dynam
togeth
src
also
lead
tyrosin
phosphoryl
critic
focal
adhes
assembl
taniyama
et
al
jnk
emerg
key
mediat
cell
migrat
interact
cytoskeleton
compon
focal
adhesionassoci
protein
huang
et
al
jnk
pathway
activ
small
gprotein
rho
effector
rock
ohtsu
et
al
ang
ii
weak
migratori
factor
importantli
enhanc
abil
vsmc
migrat
toward
pdgfbb
possibl
induc
focal
adhes
dubey
et
al
specif
suicid
capabl
apoptosi
allow
tissu
regul
cell
number
essenti
process
atherosclerosi
restenosi
isner
et
al
inde
mani
growthpromot
factor
found
also
suppress
cell
death
may
contribut
deleteri
accumul
vsmc
intim
space
ang
ii
via
r
directli
inhibit
cgmpinduc
apoptosi
vsmc
pollman
et
al
upregul
enzym
degrad
cgmp
phosphodiesteras
kim
et
al
anoth
mechan
ang
ii
exert
antiapoptot
effect
via
stimul
nox
gener
h
turn
stimul
antiapoptot
mapk
akt
activ
ushiofukai
et
al
convers
addit
antiapoptot
function
ang
ii
caus
delay
apoptosi
epithelioidshap
subtyp
vsmc
suggest
contribut
local
heterogen
plaqu
weaken
ruptur
bascand
et
al
apoptosi
alon
caus
inflamm
normal
arteri
atherosclerot
lesion
lead
plaqu
vulner
clark
et
al
thu
apoptosi
consid
benefici
detriment
proapoptot
action
ang
ii
seem
mediat
substanti
r
activ
demonstr
vivo
rs
mediat
neg
vascular
remodel
induc
vsmc
apoptosi
yamada
et
al
ace
inhibitor
acei
block
effect
r
blocker
arb
tea
et
al
interestingli
overexpress
r
alon
stimul
apoptosi
absenc
ang
ii
miura
karnik
found
ptp
like
mapk
phosphatas
mkp
link
r
via
gi
protein
coupl
uniqu
third
intracellular
loop
receptor
lehtonen
et
al
howev
signal
pathway
link
r
well
character
yet
numer
studi
shown
vsmc
capabl
produc
cytokin
vessel
wall
cytokin
consid
main
modul
inflammatori
event
atherogenesi
ang
ii
like
inflammatori
cytokin
activ
proinflammatori
transcript
factor
brasier
et
al
result
inflammatori
gene
product
grossli
subdivid
adhes
molecul
cytokin
acut
phase
reactant
prototyp
ang
iiinduc
transcript
factor
stat
nuclear
also
known
cytokineinduc
transcript
factor
ang
ii
dosedepend
stimul
product
cultur
vsmc
accompani
activ
antioxid
revers
effect
indic
role
ro
kranzhof
et
al
ang
ii
increas
express
earli
min
peak
h
fall
thereaft
wherea
activ
biphas
peak
min
h
han
et
al
cell
cycl
regulatori
gene
like
cmyc
stimul
via
transcript
factor
naftilan
et
al
taubman
et
al
ang
ii
also
stimul
transcript
intercellular
vascular
adhes
molecul
icam
vcam
manner
tummala
et
al
link
r
activ
involv
direct
phosphoryl
subunit
ribosom
kinas
rsk
ikk
pathway
appear
redoxdepend
zhang
et
al
b
addit
ang
iiinduc
vascular
inflamm
critic
regul
et
famili
transcript
factor
system
administr
ang
ii
et
mice
associ
mark
reduct
medial
hypertrophi
recruit
inflammatori
cell
vascular
wall
compar
wildtyp
mice
independ
blood
pressur
effect
zhan
et
al
therefor
like
proinflammatori
milieu
atherosclerot
lesion
least
part
consequ
ang
iiinduc
inflammatori
gene
express
ang
iistimul
product
chemokin
monocyt
chemotact
enhanc
leukocyt
accumul
vessel
wall
thought
function
local
establish
chemic
gradient
attract
monocyt
lymphocyt
express
cc
chemokin
found
creactiv
protein
crp
known
system
acut
phase
reactant
synthes
vsmc
respons
inflammatori
cytokin
ang
ii
peng
et
al
turn
crp
upregul
r
express
creat
viciou
cycl
proinflammatori
signal
furthermor
crp
establish
use
biomark
cardiovascular
risk
stratif
main
direct
physiolog
function
ang
ii
vasculatur
acut
regul
vascular
tone
therebi
control
blood
flow
variou
vascular
bed
classic
ra
function
adapt
mechan
maintain
circulatori
homeostasi
regul
blood
pressur
acut
vasoconstrict
chronic
releas
aldosteron
expans
intravascular
volum
effect
ang
ii
outsid
vasculatur
includ
modul
sympathet
tone
dipsogen
stimul
maintain
veget
autoregulatori
function
vasculatur
adult
vessel
vsmc
present
quiescent
contractil
phenotyp
insult
trigger
chang
phenotyp
ang
ii
seem
mediat
transform
may
adapt
benefici
short
term
long
term
sustain
unfavor
unstabl
vessel
architectur
prone
increas
likelihood
advers
clinic
event
patient
essenti
hypertens
divid
subgroup
low
high
plasma
renin
activ
distinct
pathophysiolog
featur
lowrenin
reninindepend
hypertens
character
saltsensit
good
respons
diuret
famili
aggreg
fisher
et
al
blockag
ra
effect
hypertens
high
plasma
renin
activ
wherea
limit
effect
lowrenin
state
patient
hypertens
multitud
structur
function
disturb
affect
compart
cell
type
vascular
wall
particular
increas
media
thick
consist
found
vessel
hypertens
anim
attenu
ang
ii
inhibit
rizzoni
et
al
increas
media
thick
due
part
hypertrophi
vsmc
also
increas
product
extracellular
matrix
lee
describ
ang
ii
potenti
increas
compon
effect
vsmc
growth
synthet
capac
figur
addit
trophic
effect
vessel
wall
implic
chronic
hypertens
prolong
contract
resist
arteri
illustr
rg
mous
endotheli
dysfunct
addit
mechan
hypertens
link
ra
activ
ang
iiinduc
vsmc
nox
enzym
react
endothelialderiv
lead
impair
endothelialdepend
vasorelax
rajagopalan
et
al
asid
vessel
wall
ang
ii
also
activ
nox
variou
tissu
recent
shown
activ
circul
cell
essenti
ang
iiinduc
hypertens
impli
circul
cell
may
provid
link
widespread
pattern
nox
activ
ro
product
variou
tissu
organ
guzik
et
al
base
clinic
observ
essenti
hypertens
insulin
resist
often
coexist
suggest
time
entiti
share
common
pathogenet
link
atherosclerosi
risk
commun
aric
studi
show
hypertens
patient
much
like
develop
type
diabet
normotens
peer
gress
et
al
intriguingli
inhibit
ra
appear
reduc
new
onset
yusuf
et
al
suggest
role
ang
ii
insulin
resist
furthermor
diabet
patient
benefit
overproport
ra
inhibit
agent
reduc
diabet
nephropathi
well
microvascular
macrovascular
complic
asid
direct
function
ang
ii
endocrin
pancrea
like
control
local
blood
flow
hormon
releas
prostaglandin
synthesi
substanti
evid
ang
ii
crosstalk
insulin
signal
vsmc
interplay
two
import
hormon
level
vsmc
attract
hypothesi
acceler
atherosclerosi
found
patient
insulin
resist
observ
made
vitro
suggest
ang
ii
stimul
vsmc
lead
serin
phosphoryl
insulin
receptor
implic
prematur
degrad
taniyama
et
al
note
ang
ii
modul
insulin
signal
multipl
level
serin
phosphoryl
insulin
receptor
also
insulin
receptor
folli
et
al
addit
ang
ii
downregul
vascular
express
tham
et
al
nuclear
hormon
receptor
transcript
factor
promot
benefici
effect
lipid
metabol
insulin
sensit
atherosclerosi
develop
moreov
exhibit
antiinflammatori
properti
neg
modul
inflammatori
gene
express
noteworthi
certain
arb
shown
directli
rindepend
activ
adipocyt
suggest
mechan
insulinsensitizingantidiabet
effect
certain
arb
schupp
et
al
develop
atherosclerot
lesion
involv
migrat
prolifer
vsmc
essenti
abovement
chronic
effect
ang
ii
vasculatur
therefor
consid
atherogen
initi
event
atherogenesi
remain
elus
clear
subsequ
chang
vsmc
phenotyp
maintain
diseas
progress
oppos
concentr
medial
thicken
observ
hypertens
atherosclerosi
result
buildup
focal
diffus
lipidladen
fibroprolif
plaqu
vessel
intima
subsequ
narrow
vessel
lumen
prior
format
plaqu
endotheli
dysfunct
upregul
adhes
molecul
occur
atherosclerosispron
vascular
segment
nakashima
et
al
ang
ii
induc
express
adhes
molecul
promot
monocyt
invas
vasculatur
addit
ang
ii
induc
express
oxldl
receptor
macrophag
subsequ
macrophag
activ
also
provid
basi
ldl
oxid
stimul
product
ro
vsmc
surprisingli
ang
ii
infus
apo
mice
significantli
enhanc
atherosclerot
lesion
progress
independ
effect
blood
pressur
weiss
et
al
convers
ang
ii
inhibit
known
reduc
atherosclerot
lesion
format
daugherti
et
al
furthermor
ang
ii
found
contribut
vsmc
senesc
implic
pathogenesi
atherosclerosi
kunieda
et
al
cell
senesc
may
promot
plaqu
instabl
sinc
loss
vsmc
lead
transform
rupturepron
plaqu
thin
fibrou
cap
lipidrich
core
geng
libbi
increas
ra
activ
emerg
key
mechan
pathogenesi
highli
preval
vascular
diseas
hypertens
atherosclerosi
therefor
vital
understand
mechan
local
ang
ii
product
ang
ii
respons
well
signal
pathway
normal
disturb
vascular
cell
function
particularli
vsmc
abund
cell
type
vessel
wall
cellular
event
initi
ang
ii
bind
r
complex
distinct
tempor
spatial
characterist
far
complet
understood
moreov
crosstalk
ra
metabol
system
lipoprotein
insulin
may
explain
common
pathogenet
link
cardiovascular
diseas
thu
advanc
knowledg
ang
ii
signal
cardiovascular
diseas
bear
enorm
potenti
identifi
novel
target
pharmacolog
intervent
